Dopo l'orario di chiusura: 9.34

Newamsterdam Pharma Company N V (NAMSW)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione

Newamsterdam Pharma Company N V Borsa (NAMSW) Ultime notizie

Newamsterdam Pharma Company N V (NAMSW)

Newamsterdam Pharma Company N V Borsa (NAMSW) Ultime notizie

Trend Tracker for (NAMS) - news.stocktradersdaily.com

Brokerages Set NewAmsterdam Pharma (NASDAQ:NAMS) PT at $43.33 - Defense World

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

NewAmsterdam Pharma Expands Clinical Team with 11 New Hires, Awards $4M in Equity Grants - Stock Titan

Examining NewAmsterdam Pharma Company NV (NAMS) stock is warranted - uspostnews.com

NewAmsterdam Pharma to Present New Clinical and Preclinical Data at 93rd EAS Congress - GlobeNewswire

Major Breakthrough: NewAmsterdam Reveals Multiple Phase 3 Trial Results for Novel Heart Drug - Stock Titan

Geode Capital Management LLC Raises Holdings in NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

NewAmsterdam Pharma Company N.V. (NAMS): Among Billionaire Andreas Halvorsen’s Stock Picks With Huge Upside Potential - Insider Monkey

Legal & General Group Plc Acquires 4,556 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

Invesco Ltd. Invests $3.87 Million in NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

NewAmsterdam Pharma (NASDAQ:NAMS) Shares Purchased by JPMorgan Chase & Co. - Defense World

A closer look at NewAmsterdam Pharma Company NV (NAMS)’s stock price trends - uspostnews.com

Is NewAmsterdam Pharma Company N.V. (NAMS) Among the Best Guru Stocks to Buy According to Wall Street Analysts? - Yahoo Finance

(NAMSW) Trading Report - news.stocktradersdaily.com

11 Best Guru Stocks to Buy According to Wall Street Analysts - Insider Monkey

Head to Head Survey: NewAmsterdam Pharma (NASDAQ:NAMS) vs. Cyclerion Therapeutics (NASDAQ:CYCN) - Defense World

Is NewAmsterdam Pharma Company NV (NASDAQ: NAMS) A Good Investment Now? - Stocksregister

Newamsterdam pharma COO Douglas Kling sells $1.65 million in shares By Investing.com - Investing.com Canada

NewAmsterdam Pharma Appoints Adele Gulfo to its Board of Directors - The Manila Times

NewAmsterdam Pharma adds Adele Gulfo to its Board By Investing.com - Investing.com South Africa

Newamsterdam pharma COO Douglas Kling sells $1.65 million in shares - Investing.com Australia

NewAmsterdam Pharma adds Adele Gulfo to its Board - Investing.com

Blockbuster Drug Veteran Who Led $12B Pfizer Unit Joins NewAmsterdam Board Before Critical Launch - Stock Titan

Arrowstreet Capital Limited Partnership Acquires New Shares in NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

Sei Investments Co. Sells 14,456 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

NewAmsterdam Pharma (NAMS): Among Billionaire Stanley Druckenmiller’s Top Stock Picks with Huge Upside Potential - Insider Monkey

KLP Kapitalforvaltning AS Purchases Shares of 6,000 NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

The Analyst Verdict: NewAmsterdam Pharma Co In The Eyes Of 6 Experts - Benzinga

NewAmsterdam Pharma (NASDAQ:NAMS) Sets New 52-Week Low – Here’s Why - Defense World

NewAmsterdam Pharma (NASDAQ:NAMS) Receives $43.33 Average Price Target from Analysts - Defense World

Where are the Opportunities in (NAMSW) - news.stocktradersdaily.com

NewAmsterdam Pharma Expands Team: 133,000 Shares Granted to Strategic New Hires - Stock Titan

NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in September - MarketScreener

American Century Companies Inc. Acquires Shares of 346,572 NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

Teacher Retirement System of Texas Makes New $276,000 Investment in NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

When (NAMS) Moves Investors should Listen - news.stocktradersdaily.com

NewAmsterdam Pharma to Present at the 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire

Leading Cardiovascular Drug Developer NewAmsterdam Sets Key Investor Presentation - Stock Titan

Newamsterdam Pharma CEO Michael Davidson sells shares for $281,000 By Investing.com - Investing.com Australia

Newamsterdam Pharma director James Topper buys $25,520 in shares - Investing.com Australia

NewAmsterdam Pharma (NASDAQ:NAMS) Shares Acquired by Swiss National Bank - Defense World

Newamsterdam pharma COO sells shares worth $376,000 By Investing.com - Investing.com Canada

Newamsterdam Pharma director James Topper buys $25,520 in shares By Investing.com - Investing.com South Africa

Simile a NAMSW